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ABSTRACT 
Influenza A and B viruses use sialylated oligosaccharide chains expressed on the surface of a host cell as the cell entry receptors. 
The type of the bond between sialic acid (SA) and the neighboring galactose residue (Gal) is one of the main characteristics 
that define the type of receptor. Influenza viruses recognize SAα2-3Gal- or SAα2-6Gal-structures on the surface of the cells. 
Influenza A viruses of avian origin bind α2-3-sialylated glycans, while the human strains bind preferentially α2-6-sialylated ones. 
However, the receptor-binding specificity of influenza B viruses has not been characterized sufficiently so far. In this study, we 
selected the escape mutants of influenza B/Florida/04/2006 strain (Yamagata-like lineage) using monoclonal antibodies (mAb) 
to hemagglutinin (HA). The analysis of the amino acid sequences of mAb-induced escape mutants revealed the single amino 
acid substitutions 40Tyr→His, 85His→Tyr, 202Asn→Lys and 242Ser→Arg in 10F4-, 8Н11-, 8Н3- and 9А3-induced HA variants, 
correspondingly. It was shown that the single amino acid substitutions 202Asn→Lys and 242Ser→Arg alter the receptor-binding 
specificity of the influenza B virus. These findings are important for the understanding of the influence of individual amino acid 
residues in HA on the receptor-binding properties of influenza B Yamagata-like lineage viruses and allow us to predict the possible 
ways of their evolution.
INTRODUCTION 
The influenza viruses B are circulating mostly in the 
human population and cause epidemics every 2-3 years. 
The disease usually has a severe form and could have 
a lethal outcome. The first step in the development 
of infection is the interaction of the influenza virus 
glycoprotein – hemagglutinin (HA) – with neuraminic 
acid – the top residue of carbohydrate chains located 
on the surface of the host cell. The N-acetyl-neuraminic 
acid (Neu5Ac) is the predominant form of sialic acids 
(SA) found in mammalian cells. It is known that the 
avian influenza A viruses have an affinity predominantly 
for hydrocarbons with the a2-3 glycoside bond between 
SA and the neighboring galactose (GA) residue while 
the human influenza A viruses interact mostly with 
the SAa2-6Gal chains [1-4]. The receptor-binding 
specificity of the influenza A viruses had been studied 
in detail and it is considered to be one of the factors 
that influence virus pathogenicity [5, 6]. As regards the 
receptor-binding specificity of influenza B viruses, there 
is rather limited data available [7-9]. Although all of the 
influenza B viruses belong to the same type, from the 
beginning of 1980s they are divided to two antigenically 
different evolutionary branches. The reference-viruses 
B/Victoria/2/1987 and B/Yamagata/16/1988 are 
considered to be the first representatives of these two 
branches [10]. At present, it is known that virus strains 
of the B/Yamagata lineage predominantly bind to the 
SAa2-6Gal oligosaccharides, while the virus strains of 
B/Victoria lineage recognize both SAa2-6Gal- and SAa2-
3Gal- chains [11].
This paper is focused on the analysis of the influence of 
the single amino acid substitutions in the HA heavy chain 
on the receptor-binding properties of the influenza virus 
B/Florida/04/2006 of the Yamagata evolutionary lineage.
MATERIALS AND METHODS
Monoclonal antibodies
Monoclonal antibodies (mAb) to the influenza B viruses 
were obtained in the laboratory of Biotechnology of 
the diagnostic preparations of Research Institute of 
Influenza according the method [12] modified as follows.
The Balb/c mice were intraperitoneally immunized 
with 70 µg of the influenza virus B/Florida/04/2006 which 
was purified by ultracentrifugation. After 3  months, 
the mice were boosted by the purified fraction of the 
surface glycoproteins of the same virus (15 µg). After 
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72 h the splenocytes of immune animals were hybridized 
with the mouse myeloma cells of the PxAg.653 line in 
10  :  1 ratio in the presence of 50% PEG-2000 solution 
in DMEM. The traditional ELISA was used in the 
course of the primary clones testing using the fraction 
of the surface glycoproteins of the influenza virus 
B/Florida/04/2006 and peroxidase labeled anti-mouse 
IgG in dilution 1:10,000 (Sigma, USA). Clones with the 
highest specific activity were selected, cultivated in HAT 
media and exposed to five-fold re-cloning. The obtained 
stable mAb producing clones were frozen. 
The hemagglutination assay
The hemagglutination assay (HA) was performed 
according to the WHO recommendations. The 50  µl 
aliquots of 0.5% suspension of chicken erythrocytes were 
added to the twofold diluted samples of virus in 50 µl of 
0.1  M phosphate buffered saline (PSB). Virus titer was 
determined as the reciprocal of the maximum dilution 
at which the agglutination of erythrocytes was observed. 
The 1% suspension of guinea pig and horse erythrocytes 
were used for receptor-binding analysis. 
The hemagglutination inhibition assay
The hemagglutination inhibition assay (HAI) was 
performed according to the recommendations of the 
WHO. Twofold dilutions of mAbs were prepared in 50 µl of 
0.1 M PBS. Then, 50 µl of the virus suspension containing 
4 HA units were added to each well. After 1 h incubation, 
100  µl of 0.5% chicken erythrocytes were added to the 
microtiter wells. The reciprocal of the maximum dilution 
of mAb at which the inhibition of the hemagglutination 
was observed was defined as HAI titer.
The selection of the escape mutants
The previously described method was used to obtain the 
escape mutants [13]. The samples of the B/Florida/04/2006 
virus were incubated with the virus specific mAbs for 1h 
at 37°C following by injection into the chicken embryos. 
Virus yield was harvested and cloned by the limiting 
dilution method. Virus antigenic properties were 
investigated by HAI with the panel of mAbs.
Sequencing
RNA of the influenza B virus was isolated using the 
QIAamp Viral RNA MiniKit (Qiagen) reagents. The reverse 
transcription of RNA was performed for 40 min at 37°C 
using the random hexamer primers and commercial kit 
Reverta-L (Interlabservice, Russia). Polymerase DiaTaq 
(Interlabservice, Russia) was used for the amplification 
step. The direct sequencing was performed by means 
of the BigDye Terminator v3.1 Cycle Sequencing Kit 
(Applied Biosystems, USA) using the genetic analyzer 
GA3130 (Applied Biosystems, USA). 
RESULTS AND DISCUSSION 
The characteristic of mAbs used in the study
In order to identify the virus-neutralizing epitopes in 
the HA molecule of influenza B viruses of the Yamagata 
lineage, we have developed four mAbs to the influenza 
virus B/Florida/04/2006, namely 8H3, 8H11, 9A3, and 
10F4. The obtained mAbs specifically inhibited viruses of 
the Yamagata lineage while they did not have any virus-
neutralizing activity regarding the influenza B viruses 
of Victorian lineage. According to the western blot 
analysis, all of the mAbs were binding to the HA1 subunit 
(unpublished data). Due to the high virus-neutralizing 
activity of these mAbs, it was possible to generate the 
escape mutants of B/Florida/04/2006 virus. 
Selected escape mutants and their antigenic 
properties
Four escape mutants of the influenza virus 
B/Florida/04/2006 corresponding to each of four 
described above mAbs were obtained. In order to identify 
the specific amino acid substitutions in HA of escape 
mutants the sequencing of HA gene was performed. It 
was found that all of the obtained escape mutants have 
the single amino acid substitutions. The amino acid 
substitutions His→Tyr at position 85 (88 according to 
the conventional numbering system for H3N2 influenza 
A virus, shown further in parentheses), and Tyr→His at 
position 40 (50) were identified in the escape mutants 
selected by using mAbs 8H11 and 10F4, respectively. 
Both substitutions are located in HA1 subunit close to 
the HA stem region of the influenza B virus (Fig. 1).
The escape mutant produced by interaction with the 
8H3 mAb has the amino acid substitution Asn→Lys at 
position 202 (193). This position is located in the HA 
Fig. 1. The localization of the amino acid substitutions in the HA 
molecule of escape mutants of influenza B/Florida/04/2006 virus 
of the Yamagata lineage (the helix 190 is shown in blue, the loop 
240 is shown in red).
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helix 190 [14] which forms the antigenic site BB1 [15]. 
The escape mutant, selected by using the mAb 9A3, 
has the amino acid substitution 242 (227) Ser→Arg. 
This amino acid residue is located in the loop 240 and 
contributes to the formation of the receptor-binding 
pocket of the type B influenza virus [16]. The three-
dimensional model of HA which shows the localization 
of the immunodominant epitopes was created based 
on the identification of the variable epitopes in escape 
mutants with the use of published  crystal structure 
data of the HA molecule of the influenza virus 
B/Yamanashi/166/1998 (PDB ID: 4M40) [16] and the 
RasMol software (version 2.7.4.2). 
The obtained escape mutants were analyzed by HAI 
with mAbs (Table 1). It was shown that all of the produced 
escape mutants completely lost their ability to interact 
with the homologous mAb. It should be mentioned that 
escape mutants 8H3, 8H11, and 10F4 retained the parent 
phenotype of binding with the heterologous mAbs 
(Table 2). At the same time, the escape mutant 9A3, in 
addition to the acquired resistance to the homologous 
mAb lost the ability to interact with the heterologous 
mAb 8H3. The analogous phenomenon has been 
described in the literature [17]. The authors showed 
that from the eight different escape mutants (V1 – V8) 
of virus B/Osaka/983/97 of Victorian lineage, selected 
with mAb 10B8, only two (V3 and V8), which have the 
amino acid substitution Lys→Thr at position 203 (202 
according to the Yamagata numbering and 193 according 
to the H3 numbering), lost their ability to interact with 
the heterologous mAb 8E6. At the same time, the escape 
mutants M1 and M2 selected with mAb 8E6 that have the 
substitution of 241(240/225) Pro→Ser were interacting 
with the heterologous mAb 10B8. This suggested that the 
amino acid residue at position 203 (202/193) is part of the 
8E6 mAb epitope or that it is located in close proximity 
to this epitope. 
Escape mutants receptor-binding specificity
As it was shown recently, the influenza B virus strains 
of the Yamagata lineage interact predominantly with 
the SAa2-6Gal-containing carbohydrate chains while 
the Victorian isolates recognize both types of sialosides 
[11]. In order to explore the effect of the different HA 
amino acid substitutions on the virus receptor-binding 
specificity, we analyzed the relative activity of escape 
mutants with respect to the erythrocytes of different 
animal species (Table 2). It is known that the structures 
of the sialylated oligosaccharide chains, expressed on 
the surface of erythrocytes of chicken, guinea pigs, and 
horses primarily differ by the bond type between the SA 
and Gal [18]. 
As is shown in Table  2, the wild type virus 
B/Florida/04/2006 did not show any binding with the 
horse erythrocytes in contrast to the guinea pig and 
chicken erythrocytes. That allows to assume that this 
virus strain predominantly interacts with the a2-6-
sialylated chains. Interaction patterns of the escape 
mutants 8H11 (85His→Tyr) and 10F4 (40Tyr→His) with 
the corresponding erythrocytes were similar to those of 
the wild type virus. However, the mutant 8H3 with the 
substitution 202Asn→Lys acquired the capability to 
interact with the horse erythrocytes, which have mostly 
SAa2-3Gal-terminated oligosaccharides expressed on 
their surface. As it was shown previously [19], the majority 
of the amino acid residues surrounding the influenza B 
virus HA receptor-binding pocket are identical for the 
virus strains of the Yamagata and Victorian lineages with 
the exception of the several amino acids at positions 
163, 198, 202, and 203 (numbering for the Victorian 
lineage). In addition, it should be mentioned that there 
is no potential N-glycosylation site at 163Asn in the HA 
of the Yamagata-like viruses.  Furthermore, while the 
Victorian lineage viruses have the negatively charged 
Table 1. The interaction of the escape mutants with the monoclonal antibodies 8H3, 8H11, 9A3, and 10F4 in HAI 
Viruses The titer of the mAb in HAI Amino acid substitutions in HA
8H3 8H11 9A3 10F4
B/Florida/04/2006 20480 160 5120 320 -
Escape mutant 8H3 20 80 2560 160 202Asn→Lys
Escape mutant 8H11 20480 <20 2560 160 85His→Tyr
Escape mutant 9A3 <20 80 <20 160 242Ser→Arg
Escape mutant 10F4 20480 160 2560 <20 40Tyr→His
Table 2. The receptor-binding properties of the escape mutants of the influenza B/Florida/04/2006 virus







B/Florida/04/2006 128 128 ≤ 2 -
Escape mutant 8H3 128 64 64 202Asn→Lys
Escape mutant 8H11 128 128 <2 85His→Tyr
Escape mutant 9A3 128 64 8-16 242Ser→Arg
Escape mutant 10F4 64 64 <2 40Tyr→His
a Carbohydrate chains are terminated with both SAa2-3Gal and SAa2-6Gal.
b Carbohydrate chains are predominantly terminated with the SAa2-6Gal.
c Predominantly contain SAa2-3Gal-terminated carbohydrate chains.
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198Glu, neutral 202Ala, and positively charged 203Lys 
residues in the helix 190, Yamagata-like viruses contain 
positively charged 197Lys, 201Lys, and neutral 202Asn, 
respectively. It is assumed that these four amino acid 
residues can play an important role in the recognition 
of the sialylated chains [11]. As is shown in Table  2, 
the substitution of the Asn to Lys at position 202 (203 
according to the Victorian lineage numbering) affected 
the HA properties apparently by broadening its binding 
capabilities. Thus, the escape mutant 8H3, in contrast 
to the wild type virus, binds to the horse erythrocytes 
(with mostly a2-3-sialylated chains) preserving at the 
same time the parent phenotype of the agglutination of 
the guinea pig erythrocytes (with mostly a2-6-sialylated 
chains). It should be mentioned that the wild type 
B/Florida/04/2006 as well as all the escape mutants 
contain Lys at positions 197 (198 for the Victorian lineage) 
and 201 (202 for the Victorian lineage), which is typical 
for the Yamagata-like viruses. As was shown previously, 
the virus B/Victoria/504/2000, which interacts with the 
receptors with oligosaccharides terminated with SAa2-
6Gal, gained substitutions 141Gly→Glu, 162Arg→Met, 
and 196Asp→Tyr in the course of adaptation to growth 
in chicken embryos. As a result, the receptor specificity 
of the adapted virus HA has extended by inclusion of the 
SAa2-3Gal containing oligosaccharides [7]. The analysis 
of the virus B/Florida/04/2006 HA sequence and all the 
escape mutants showed that there were no substitutions 
at these positions – all the obtained escape mutants had 
141Gly, 162Arg, and 196Asp residues as well as the wild 
type virus, which was used for selection. Furthermore, we 
discovered that neither the virus B/Florida/04/2006 nor 
any of the obtained escape mutants had substitution at 
position 95Phe. It is known that the amino acid residue 
at this position plays an important role in the formation 
of the receptor-binding pocket and defines the lower 
influenza virus B affinity for the receptors in comparison 
with the influenza virus A (98Tyr) [20]. 
One more escape mutant – 9A3 – gained the ability to 
interact with horse erythrocytes as well as 8H3. Escape 
mutant 9A3 has the amino acid substitution at 242(227)
Ser→Arg that is  the part  of the loop 240. The loop 240 and 
helix 190 are located in the distance from the membrane 
and form the top and left edge of the HA receptor-binding 
pocket of the influenza B viruses. The rearrangement of 
the loop 240 side chains could significantly change the 
HA antigenic properties [16]. There is a hydrogen bond 
between the residues 242(227) Ser and 240(225) Pro. The 
substitution of Ser by Arg at position 242 probably breaks 
this hydrogen bond that has an impact not only on the 
HA antigenic properties but also on its receptor-binding 
specificity. The assumption about the mutual influence 
of the amino acid residues located in the loop 240 and 
helix 190 is also proven by the fact that escape mutant 
9A3 lost its ability to interact with mAb 8H3.
CONCLUSION 
The results of this investigation showed that the amino 
acid substitutions in the HA molecule that appear due 
to the escape of the influenza virus B/Florida/04/2006 
from the neutralizing action of mAbs 8H3, 8H11, 9A3, 
or 10F4 not only influence the virus antigenic properties 
but also could change its receptor specificity. Thus, 
the substitution of Asn at position 202 by Lys in HA 
molecule probably broadens the spectrum of the ligands 
recognized by this virus - in addition to the erythrocytes 
containing mostly the SAα2-6Gal- chains (guinea pig), 
the virus began to interact with the erythrocytes having 
mostly the SAα2-3Gal- chains. The amino acid residue 
at position 242 (substitution of Ser by Arg) could also 
influence the influenza virus B/Florida/04/2006 receptor-
binding properties.
It is necessary to point out that it is very important 
to monitor the receptor-binding characteristics of the 
circulating and emerging influenza A and B viruses 
because the repertoire of HA receptors defines tissue 
tropism and, consequently, virulence of the virus [5, 6]. 
Thus, the patients infected with the influenza B virus 
strains that bind not only to the SAa2-6Gal-chains but 
also SAa2-3Gal ones (avian type) are prone to developing 
pneumonia and more often have the symptoms of 
gastrointestinal tract damage [11]. In general, the 
knowledge of the mechanisms of the virus interaction 
with the host cell, which is directly associated with 
the HA receptor-binding properties, gives the key to 
understanding the possible trends of the virus evolution. 
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